Headquarters
20 PARK PLZ STE 424, BOSTON, MA 02116-4335, US
BOSTON, MA, US
CERVOMED, INC.
From the company
CervoMed is a clinical stage biotechnology company focused on developing treatments for age-related neurologic disorders. Its lead product candidate, neflamapimod, is an investigational, orally administered, small molecule brain penetrant that inhibits the protein kinase p38 alpha, and is in clinical development for neurodegenerative diseases such as dementia with Lewy bodies, frontotemporal dementia and recovery after stroke. Until August 2023, CervoMed was known as EIP Pharma Inc., now a wholly-owned subsidiary.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.